CELLING
LIES
National
Review; September 26, 2002
Celling
Lies: More Spurious Stem Cell
Claims
by
Michael Fumento
"Electricity
Appears Worthless for Illumination." If you saw such a headline you'd
be rather skeptical, wouldn't you? Yet here we go again with another massively publicized study purporting to show that adult stem
cells don't work, notwithstanding
that they've been saving lives for over a decade now. "Promise of
Adult Stem Cells Put in Doubt," proclaimed UPI. "Study Deals Blow to
Abilities of Adult Stem Cells," declared Scientific American in its online publication. "Study Finds Adult Blood Stem Cells Will Not
Transform into Other Tissue
Cells," insisted the Associated Press.
The
fuss concerns an article in the highly respected journal Science detailing
efforts of Stanford researchers to trace the development of blood stem
cells after placing them into mice whose bone marrow had been destroyed. They
reported that blood stem cells replenished marrow but appeared worthless for creating other tissues.
"Blood-forming
stem cells from adults make blood," primary researcher Irving Weissman
insisted to UPI. "They don't make brain; they don't make heart muscle
or any of these things."
Such
smugness from a scientist who should know a single study never proves anything.
As it happens, a report published in Nature Medicine in November 2000 showed that such cells when injected into mice rebuilt
liver tissue. A minor co-author of
the piece was named Irving Weissman.
Weissman's
sureness was just for show.
Indeed,
"The Stanford paper is the one at odds with the bulk of the published literature,"
Indiana State University biologist David Prentice told me.
While
nobody knows yet just how capable non-embryonic stem cells will prove, we
know they will be extremely useful because they have been.
Ever
hear of bone marrow or umbilical-cord-blood transplants? It's the stem cells
in the marrow and blood that makes them work. They've been used therapeutically
since the 1980s and now some 70 different diseases, primarily forms
of leukemia, are treated with them.
True,
these comprise direct infusions rather than the next step of "reprogramming"
the stem cells outside the body to make them into various types of mature cells.
But
there's tremendous progress here, too. As of last year, over 30 different anti-cancer
applications alone involving non-embryonic stem cell therapies on humans had been reported in peer-reviewed medical literature.
Over 100 non-embryonic-stem-cell
experiments in animals have shown success against a vast array of diseases.
The
very newspapers that now pooh-pooh adult stem cells were only days earlier
reporting on the almost-miraculous cure of a Dutch child afflicted with
"bubble boy syndrome." His immune system was worthless. But it was restored
when stem cells from his marrow were removed, cultured, and injected back
into him.
Even
if blood stem cells were worthless for tissue, we'd still have other types
of stem cells that have been cultivated not just from marrow and umbilical cords but also from placentas, amniotic fluid, skin,
brains, spinal cords, dental pulp,
muscles, blood vessels, corneas, retinas, livers, pancreases, hair follicles, and even liposuctioned fat.
Catherine
Verfaillie and her co-workers at the University of Minnesota's Stem Cell
Institute recently published a report in Science's main competitor, Nature,
suggesting that a certain type of marrow stem cells may give rise to almost
any type of tissue in the body. They have isolated them from the marrow
of mice, rats and people and so far have transformed them into cells of
blood, the gut, liver, lung, brain, and other organs.
Yet
time and again a single study like the Stanford one is shoved forward to show
that non-embryonic-stem-cell therapy is the biological version of cold fusion.
Why?
Some
of the media coverage may reflect sheer ignorance. But Science and Weissman
know better. They're both part of a deliberate disinformation campaign
by those who see embryonic stem cell research and non-embryonic stem cell
research locked in mortal combat.
The
worse the non-embryonics look, the stronger the case for using embryonic stem
cells. With every breakthrough in non-embryonic research comes the need to
turn up the screech knob on the disinformation box.
That's
because while the government can make grants on a whim, venture capital
flows towards success. Thus almost all capital is going to non-embryonic
research. Those working with embryonic cells are desperate for government
funds.
It's
hardly surprising, therefore, that Dr. Michael D. West, head of Advanced Cell
Technology in Worcester, Mass., told the AP that the Stanford study indicates "stem cells from the bone marrow will not be a
practical source for many cell
types needed" to treat disease. That is, it wouldn't be surprising if
the AP had told you West's company does research with embryonic stem cells.
Just
as a 30-year-old panhandler will claim to be a Vietnam vet to shake money
out of your pockets, those desperate for funding are obviously not above misrepresenting research to keep their labs running.
But
whatever the promises of embryonic research, the actual applications are coming
from non-embryonic stem cells. The miracles they have already performed
are but little compared to those of which they are capable. We dare not
let that progress be hamstrung by the politics of pork.
[Pro-Life Infonet Note: Michael Fumento is a senior fellow at the Hudson Institute in Washington, D.C. where he's currently writing BioEvolution: How Biotechnology is Changing our World.]